Genomics

Dataset Information

Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers


ABSTRACT: Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers

PROVIDER: PRJNA971167 | ENA |

REPOSITORIES: ENA